Cargando…

Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia

PURPOSE: To evaluate the performance and safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) for improvement of uncorrected near, intermediate and distance visual acuity in phakic subjects with myopia and presbyopia. DESIGN: Prospective multicenter study. METHODS: Presbyopi...

Descripción completa

Detalles Bibliográficos
Autores principales: Packer, Mark, Alfonso, Jose F, Aramberri, Jaime, Elies, Daniel, Fernandez, Joaquin, Mertens, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509320/
https://www.ncbi.nlm.nih.gov/pubmed/32982164
http://dx.doi.org/10.2147/OPTH.S271858
_version_ 1783585570096676864
author Packer, Mark
Alfonso, Jose F
Aramberri, Jaime
Elies, Daniel
Fernandez, Joaquin
Mertens, Erik
author_facet Packer, Mark
Alfonso, Jose F
Aramberri, Jaime
Elies, Daniel
Fernandez, Joaquin
Mertens, Erik
author_sort Packer, Mark
collection PubMed
description PURPOSE: To evaluate the performance and safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) for improvement of uncorrected near, intermediate and distance visual acuity in phakic subjects with myopia and presbyopia. DESIGN: Prospective multicenter study. METHODS: Presbyopic subjects who required an EDOF ICL in the range of −0.50 D to −18.00 D, exhibited ≤ 0.75 D refractive astigmatism and required from +1.00 to +2.50 D reading add were implanted bilaterally. Assessments at 6 months included uncorrected near, intermediate and distance visual acuities, defocus curves, contrast sensitivity, responses to the National Eye Institute Refractive Error Quality of Life Questionnaire and a Task Assessment Questionnaire. RESULTS: A total of 34 subjects completed the study. Investigators targeted emmetropia in all eyes. Mean binocular uncorrected near, intermediate and distance visual acuities measured logMAR −0.01 ± 0.05 (20/20), −0.02 ± 0.08 (20/19) and 0.07 ± 0.10 (20/23), respectively. Mean monocular uncorrected near, intermediate and distance visual acuities measured logMAR 0.068 ± 0.09 (20/23), 0.062 ± 0.10 (20/23) and 0.16 ± 0.12 (20/29). There were no clinically or statistically significant differences in contrast sensitivity between baseline and 6 months under any testing conditions. Subjects reported significant improvements in measures of vision-related quality of life and ability to perform tasks at all distances without glasses or contact lenses. Overall, satisfaction with the EDOF ICL was high: postoperatively, 91.2% of subjects were satisfied with their vision. CONCLUSION: This multicenter, prospective clinical investigation demonstrated the ability of the EDOF ICL to correct myopia and presbyopia, resulting in improvement of uncorrected near, intermediate and distance visual acuity without compromising the quality of vision. The EDOF ICL allowed subjects to perform tasks of daily living without glasses or contact lenses. Subjects reported significant improvements in quality of life with high levels of spectacle independence and satisfaction.
format Online
Article
Text
id pubmed-7509320
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75093202020-09-24 Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia Packer, Mark Alfonso, Jose F Aramberri, Jaime Elies, Daniel Fernandez, Joaquin Mertens, Erik Clin Ophthalmol Clinical Trial Report PURPOSE: To evaluate the performance and safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) for improvement of uncorrected near, intermediate and distance visual acuity in phakic subjects with myopia and presbyopia. DESIGN: Prospective multicenter study. METHODS: Presbyopic subjects who required an EDOF ICL in the range of −0.50 D to −18.00 D, exhibited ≤ 0.75 D refractive astigmatism and required from +1.00 to +2.50 D reading add were implanted bilaterally. Assessments at 6 months included uncorrected near, intermediate and distance visual acuities, defocus curves, contrast sensitivity, responses to the National Eye Institute Refractive Error Quality of Life Questionnaire and a Task Assessment Questionnaire. RESULTS: A total of 34 subjects completed the study. Investigators targeted emmetropia in all eyes. Mean binocular uncorrected near, intermediate and distance visual acuities measured logMAR −0.01 ± 0.05 (20/20), −0.02 ± 0.08 (20/19) and 0.07 ± 0.10 (20/23), respectively. Mean monocular uncorrected near, intermediate and distance visual acuities measured logMAR 0.068 ± 0.09 (20/23), 0.062 ± 0.10 (20/23) and 0.16 ± 0.12 (20/29). There were no clinically or statistically significant differences in contrast sensitivity between baseline and 6 months under any testing conditions. Subjects reported significant improvements in measures of vision-related quality of life and ability to perform tasks at all distances without glasses or contact lenses. Overall, satisfaction with the EDOF ICL was high: postoperatively, 91.2% of subjects were satisfied with their vision. CONCLUSION: This multicenter, prospective clinical investigation demonstrated the ability of the EDOF ICL to correct myopia and presbyopia, resulting in improvement of uncorrected near, intermediate and distance visual acuity without compromising the quality of vision. The EDOF ICL allowed subjects to perform tasks of daily living without glasses or contact lenses. Subjects reported significant improvements in quality of life with high levels of spectacle independence and satisfaction. Dove 2020-09-18 /pmc/articles/PMC7509320/ /pubmed/32982164 http://dx.doi.org/10.2147/OPTH.S271858 Text en © 2020 Packer et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Clinical Trial Report
Packer, Mark
Alfonso, Jose F
Aramberri, Jaime
Elies, Daniel
Fernandez, Joaquin
Mertens, Erik
Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia
title Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia
title_full Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia
title_fullStr Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia
title_full_unstemmed Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia
title_short Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia
title_sort performance and safety of the extended depth of focus implantable collamer(®) lens (edof icl) in phakic subjects with presbyopia
topic Clinical Trial Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509320/
https://www.ncbi.nlm.nih.gov/pubmed/32982164
http://dx.doi.org/10.2147/OPTH.S271858
work_keys_str_mv AT packermark performanceandsafetyoftheextendeddepthoffocusimplantablecollamerlensedoficlinphakicsubjectswithpresbyopia
AT alfonsojosef performanceandsafetyoftheextendeddepthoffocusimplantablecollamerlensedoficlinphakicsubjectswithpresbyopia
AT aramberrijaime performanceandsafetyoftheextendeddepthoffocusimplantablecollamerlensedoficlinphakicsubjectswithpresbyopia
AT eliesdaniel performanceandsafetyoftheextendeddepthoffocusimplantablecollamerlensedoficlinphakicsubjectswithpresbyopia
AT fernandezjoaquin performanceandsafetyoftheextendeddepthoffocusimplantablecollamerlensedoficlinphakicsubjectswithpresbyopia
AT mertenserik performanceandsafetyoftheextendeddepthoffocusimplantablecollamerlensedoficlinphakicsubjectswithpresbyopia